🇺🇸 FDA

Company profile · Sponsor

AOP

AOP Orphan Pharmaceuticals GmbH

E24C9CA · EMA pharma EU
Pipeline
2
Drugs
0
Patents
0

Quick answer

AOP (E24C9CA) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

Company facts

Ticker E24C9CA
Exchange EMA
Company type pharma
Headquarters EU

Pipeline (2)

Search pipeline →

  1. TREPaed_10, TREPaed_5, TREPaed_0.5, TREPaed_2.5, TREPaed_1

    AOP

    Pulmonary Arterial Hypertension (PAH)

    phase 3 small molecule active

    1 trial

  2. LB-208, LB-208

    AOP

    Relapse or refractory (r/r) acute myeloid leukaemia (AML) and r/r higher-risk (HR) myelodysplastic syndrome (MDS)

    phase 2 small molecule active

    1 trial

Frequently asked questions

What is AOP?

AOP (E24C9CA) is a pharma company. headquartered in EU. listed on EMA. NovaPharmaNews links 2 pipeline programs, 0 drugs, and 0 patents to this profile..

What pipeline programs does AOP sponsor?

We track 2 ClinicalTrials.gov-linked programs for AOP, including TREPaed_10, TREPaed_5, TREPaed_0.5, TREPaed_2.5, TREPaed_1 and 1 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does AOP company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.